UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-17 | Future report Set alerts | |
| Q2 2022 | 2022-07-20 | 1.43 | 1.43 |
| Q1 2022 | 2022-04-20 | -4.24 | -4.24 |
| Q4 2021 | 2022-01-19 | -1.60 | -1.60 |
| Q3 2021 | 2021-10-19 | -1.02 | -1.02 |
| Q2 2021 | 2021-07-20 | -3.91 | -3.91 |
| Q1 2021 | 2021-04-19 | -7.50 | -7.50 |
| Q4 2020 | 2021-01-20 | -7.00 | -7.00 |
| Q3 2020 | 2020-10-14 | -8.16 | -8.16 |
| Q2 2020 | 2020-07-21 | -9.31 | -9.31 |
| 2016-07-12 | Upgrade | Deutsche Bank AG | Hold to Buy | |
| 2016-07-06 | Downgrade | Credit Suisse Group AG | Outperform to Neutral | $64.00 to $42.00 |
| 2016-06-25 | Reiterated Rating | Credit Suisse | Underweight | |
| 2016-06-25 | Reiterated Rating | Credit Suisse Group AG | Underweight | |
| 2016-06-15 | Reiterated Rating | Morgan Stanley | Overweight | |
| 2016-04-28 | Reiterated Rating | Morgan Stanley | Overweight | $67.00 to $58.00 |
| 2016-04-23 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-04-23 | Reiterated Rating | Stephens | Hold | |
| 2016-04-22 | Lower Price Target | Stephens | Equal Weight | $61.00 to $58.00 |
| 2016-04-22 | Downgrade | Sterne Agee CRT | Buy to Neutral | $70.00 to $56.00 |
| 2016-04-22 | Lower Price Target | Stifel Nicolaus | Buy | $75.00 to $70.00 |
| 2016-04-22 | Lower Price Target | Cowen and Company | Outperform | $65.00 to $62.00 |
| 2016-04-15 | Reiterated Rating | Buckingham Research | Buy | |
| 2016-04-12 | Lower Price Target | Credit Suisse | Outperform | $73.00 to $69.00 |
| 2016-04-12 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $66.50 |
| 2016-04-09 | Reiterated Rating | Deutsche Bank | Hold | |
| 2016-04-09 | Reiterated Rating | Deutsche Bank AG | Hold | |
| 2016-04-01 | Downgrade | Deutsche Bank | Buy to Hold | $75.00 to $62.00 |
| 2016-03-31 | Reiterated Rating | Credit Suisse | Outperform | |
| 2016-03-29 | Initiated Coverage | Stephens | Equal Weight | $64.00 |
| 2016-03-24 | Downgrade | Raymond James | Outperform to Market Perform | |
| 2016-03-24 | Downgrade | Raymond James Financial Inc. | Outperform to Market Perform | |
| 2016-03-04 | Reiterated Rating | Buckingham Research | Buy | |
| 2016-03-03 | Reiterated Rating | Sterne Agee CRT | Buy | $70.00 |
| 2016-02-11 | Reiterated Rating | Credit Suisse | Outperform | |
| 2016-02-06 | Reiterated Rating | Morgan Stanley | Overweight | |
| 2016-02-04 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $77.00 to $66.50 |
| 2016-01-24 | Lower Price Target | Credit Suisse | Outperform | $84.00 to $80.00 |
| 2016-01-22 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-01-22 | Reiterated Rating | Credit Suisse | Outperform | $84.00 to $80.00 |
| 2016-01-18 | Lower Price Target | Credit Suisse | Outperform | $87.00 to $84.00 |
| 2016-01-07 | Reiterated Rating | Credit Suisse | Outperform | $88.00 to $87.00 |
| 2015-12-23 | Reiterated Rating | Oppenheimer | Buy | |
| 2015-12-23 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
| 2015-12-21 | Boost Price Target | Deutsche Bank | Buy | $74.00 to $75.00 |
| 2015-12-17 | Reiterated Rating | Buckingham Research | Buy | |
| 2015-12-08 | Reiterated Rating | Barclays | Overweight | $78.00 |
| 2015-12-08 | Reiterated Rating | Barclays PLC | Overweight | $78.00 |
| 2015-12-03 | Reiterated Rating | Raymond James | Strong-Buy | |
| 2015-12-01 | Reiterated Rating | Buckingham Research | Buy | $98.00 |
| 2015-10-24 | Reiterated Rating | Buckingham Research | Buy | $98.00 |
| 2015-10-23 | Boost Price Target | Credit Suisse | $85.00 to $88.00 | |
| 2015-10-13 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $81.00 to $77.50 |
| 2015-10-12 | Reiterated Rating | Morgan Stanley | Overweight | $96.00 |
| 2015-10-12 | Reiterated Rating | Deutsche Bank | Buy | |
| 2015-10-09 | Boost Price Target | Sterne Agee CRT | Buy | $70.00 to $78.00 |
| 2015-10-09 | Boost Price Target | Deutsche Bank | $72.00 to $74.00 | |
| 2015-10-09 | Reiterated Rating | Credit Suisse | Top Pick | |
| 2015-09-25 | Boost Price Target | Cowen and Company | $75.00 to $80.00 | |
| 2015-09-22 | Boost Price Target | Raymond James | Outperform | $70.00 to $72.00 |
| 2015-09-18 | Boost Price Target | Wolfe Research | Outperform | $85.00 to $88.00 |
| 2015-09-10 | Reiterated Rating | Deutsche Bank | Buy | |
| 2015-09-10 | Reiterated Rating | Imperial Capital | Hold | $65.00 |
| 2015-09-09 | Reiterated Rating | S&P Equity Research | Buy | |
| 2015-09-03 | Reiterated Rating | S&P Equity Research | Strong-Buy | $70.00 |
| 2015-09-02 | Lower Price Target | Credit Suisse | Outperform | $80.00 to $77.00 |
| 2015-08-31 | Reiterated Rating | Cowen and Company | Outperform | $75.00 |
| 2015-08-24 | Initiated Coverage | Standpoint Research | Buy | $70.00 |
| 2015-08-04 | Reiterated Rating | Morgan Stanley | Overweight | $93.00 to $92.00 |
| 2015-07-30 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $78.50 to $81.00 |
| 2015-07-25 | Reiterated Rating | Imperial Capital | Hold | |
| 2015-07-24 | Lower Price Target | Imperial Capital | In to In-Line | $75.00 to $65.00 |
| 2015-07-24 | Upgrade | Deutsche Bank | Hold to Buy | $63.00 to $72.00 |
| 2015-07-06 | Upgrade | Sterne Agee CRT | Fairly Valued to Buy | $70.00 |
| 2015-07-06 | Upgrade | CRT Capital | Fair Value to Buy | $70.00 |
| 2015-06-23 | Initiated Coverage | Morgan Stanley | Overweight | $86.00 |
| 2015-06-19 | Lower Price Target | Credit Suisse | $69.00 to $68.00 | |
| 2015-06-18 | Lower Price Target | Barclays | Overweight | $88.00 to $78.00 |
| 2015-06-12 | Reiterated Rating | Goldman Sachs | Buy | $89.00 to $81.00 |
| 2015-06-12 | Reiterated Rating | Goldman Sachs Group Inc. | Buy | $89.00 to $81.00 |
| 2015-06-10 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $89.00 to $78.50 |
| 2015-06-10 | Lower Price Target | Deutsche Bank | Hold | $70.00 to $63.00 |
| 2015-06-09 | Lower Price Target | Cowen and Company | Outperform | $83.00 to $75.00 |
| 2015-06-08 | Downgrade | Raymond James | Strong-Buy to Outperform | $82.00 to $68.00 |
| 2015-05-28 | Reiterated Rating | Credit Suisse | Outperform | |
| 2015-05-09 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $93.50 to $89.00 |
| 2015-04-27 | Reiterated Rating | Deutsche Bank | Hold | $70.00 |
| 2015-04-27 | Downgrade | CRT Capital | Buy to Fair Value | $91.00 to $70.00 |
| 2015-04-24 | Upgrade | Evercore Partners Inc. | Hold to Buy | |
| 2015-04-24 | Lower Price Target | Stifel Nicolaus | Buy | $85.00 to $80.00 |
| 2015-04-24 | Upgrade | Evercore ISI | Hold to Buy | $80.00 |
| 2015-04-01 | Downgrade | Deutsche Bank | Buy to Hold | $85.00 to $70.00 |
| 2015-03-09 | Reiterated Rating | Credit Suisse | Outperform | $98.00 to $66.67 |
| 2015-02-18 | Initiated Coverage | Bank of America | Neutral | $75.00 |
| 2015-02-18 | Initiated Coverage | Bank of America Corp. | Neutral | $75.00 |
| 2015-02-02 | Upgrade | Raymond James | Outperform to Strong-Buy | $60.00 to $88.00 |
| 2015-01-23 | Set Price Target | Credit Suisse | Buy | $100.00 |
| 2015-01-23 | Boost Price Target | Deutsche Bank | Buy | $80.00 to $85.00 |
| 2015-01-23 | Boost Price Target | Stifel Nicolaus | Buy | $85.00 to $90.00 |
| 2015-01-23 | Reiterated Rating | Imperial Capital | In to In-Line | $68.00 to $75.00 |
| 2015-01-16 | Boost Price Target | Barclays | Overweight | $76.00 to $88.00 |
| 2015-01-15 | Upgrade | Bank of America | Underperform to Neutral | |
| 2015-01-14 | Boost Price Target | Imperial Capital | In-Line | $63.00 to $68.00 |
| 2015-01-13 | Boost Price Target | CRT Capital | Buy | $73.00 to $75.00 |
| 2015-01-06 | Boost Price Target | Buckingham Research | $67.00 to $89.00 | |
| 2014-12-15 | Boost Price Target | Deutsche Bank | Buy | $50.00 to $80.00 |
| 2014-12-10 | Boost Price Target | Imperial Capital | In-Line | $47.00 to $63.00 |
| 2014-12-10 | Upgrade | Barclays | Underweight to Overweight | $52.00 to $76.00 |
| 2014-12-02 | Boost Price Target | Credit Suisse | Outperform | $71.00 to $79.00 |
| 2014-11-24 | Boost Price Target | CRT Capital | Buy | $57.00 to $65.00 |
| 2014-10-15 | Reiterated Rating | Barclays | Underweight | $51.00 to $52.00 |
| 2014-10-15 | Upgrade | Avondale Partners | Market Perform to Outperform | |
| 2014-10-10 | Reiterated Rating | CRT Capital | Buy | $53.00 to $57.00 |
| 2014-10-09 | Reiterated Rating | Bank of America | Underperform | $40.00 to $44.00 |
| 2014-10-09 | Reiterated Rating | Credit Suisse | Focus List to Outperform | $2.75 to $40.25 |
| 2014-09-15 | Boost Price Target | Barclays | Underweight | $48.00 to $51.00 |
| 2014-09-08 | Initiated Coverage | Credit Suisse | Outperform | $68.00 |
| 2014-07-30 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $43.50 to $60.50 |
| 2014-07-28 | Boost Price Target | Barclays | Underweight | $46.00 to $48.00 |
| 2014-07-25 | Reiterated | Cowen | Outperform | $50 to $52 |
| 2014-07-25 | Reiterated Rating | Raymond James | Outperform | $50.00 to $55.00 |
| 2014-07-25 | Reiterated Rating | CRT Capital | Buy | $49.00 to $54.00 |
| 2014-07-25 | Boost Price Target | Cowen and Company | Outperform | $50.00 to $52.00 |
| 2014-07-11 | Reiterated Rating | Barclays | Underweight | $42.00 to $46.00 |
| 2014-07-11 | Reiterated Rating | Imperial Capital | In-Line | |
| 2014-06-26 | Downgrade | Imperial Capital | Outperform to In-Line | $55.00 to $47.00 |
| 2014-05-01 | Reiterated Rating | JPMorgan Chase & Co. | Neutral | $43.50 |
| 2014-04-25 | Lower Price Target | Cowen and Company | Outperform | $56.00 to $50.00 |
| 2014-04-17 | Lower Price Target | Barclays | Underweight | $50.00 to $46.00 |
| 2014-04-07 | Lower Price Target | Goldman Sachs | $60.00 to $59.00 | |
| 2014-03-24 | Upgrade | Raymond James | Market Perform to Outperform | $52.00 |
| 2014-03-14 | Reiterated Rating | Bank of America | Underperform | $28.00 to $33.50 |
| 2014-02-25 | Initiated Coverage | Stifel Nicolaus | Buy | $60.00 |
| 2014-02-04 | Boost Price Target | Barclays | Underweight | $38.00 to $50.00 |
| 2014-01-31 | Upgrade | JPMorgan Chase & Co. | Underweight to Neutral | $40.50 to $53.50 |
| 2014-01-23 | Boost Price Target | Cowen and Company | Outperform | $46.00 to $56.00 |
| 2014-01-14 | Boost Price Target | CRT Capital | Buy | $50.00 to $55.00 |
| 2014-01-10 | Boost Price Target | Imperial Capital | Outperform | $42.00 to $49.00 |
| 2014-01-08 | Initiated Coverage | Atlantic Securities | Overweight | |
| 2013-11-22 | Upgrade | Goldman Sachs | Neutral to Buy | $35.00 to $44.00 |
| 2013-11-21 | Boost Price Target | Imperial Capital | Outperform | $36.00 to $42.00 |
| 2013-11-20 | Boost Price Target | CRT Capital | Buy | $40.00 to $50.00 |
| 2013-11-20 | Reiterated Rating | Deutsche Bank | Buy | $40.00 |
| 2013-11-08 | Downgrade | Barclays | Equal Weight to Underweight | $30.00 to $38.00 |
| 2013-10-25 | Upgrade | Buckingham Research | Neutral to Buy | |
| 2013-10-25 | Downgrade | JPMorgan Chase & Co. | Neutral to Underweight | $32.50 to $25.00 |
| 2013-09-27 | Downgrade | Buckingham Research | Buy to Neutral | |
| 2013-09-18 | Boost Price Target | Imperial Capital | Outperform | $35.00 to $36.00 |
| 2016-07-12 | Upgrade | Deutsche Bank AG | Hold to Buy | |
| 2016-07-06 | Downgrade | Credit Suisse Group AG | Outperform to Neutral | $64.00 to $42.00 |
| 2016-06-25 | Reiterated Rating | Credit Suisse | Underweight | |
| 2016-06-25 | Reiterated Rating | Credit Suisse Group AG | Underweight | |
| 2016-06-15 | Reiterated Rating | Morgan Stanley | Overweight |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In UAL 381 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 35.75M |
| PRIMECAP MANAGEMENT CO/CA/ | 24.48M |
| BlackRock Inc. | 16.61M |
| Capital International Investors | 11.95M |
| CITADEL ADVISORS LLC | 11.26M |
| STATE STREET CORP | 9.98M |
| BlackRock Institutional Trust Company, N.A. | 7.56M |
| GEODE CAPITAL MANAGEMENT, LLC | 6.64M |
| BlackRock Fund Advisors | 6.28M |
| U S GLOBAL INVESTORS INC | 6.00M |
| JANUS CAPITAL MANAGEMENT LLC | 5.02M |
| UBS Group AG | 4.54M |
| FMR LLC | 4.02M |
| PAR CAPITAL MANAGEMENT INC | 3.83M |
| BLACKROCK ADVISORS LLC | 3.72M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| PAR INVESTMENT PARTNERS LP | 4.36% (16294711) | ENT / OWW / PCYO / POZN / RMGN / UAL / |
| SMISEK JEFFERY A Chairman, President & CEO | 0.11% (408730) | NOV / UAL / |
| MUNOZ OSCAR | 0.05% (198392) | CSX / UAL / |
| KIRBY J SCOTT President | 0.03% (107307) | AAL / UAL / |
| TILTON GLENN F | 0.02% (89689) | ABBV / ABT / PSX / UAL / |
| COMPTON JAMES E Vice Chair & Chief Rev Officer | 0.02% (74556) | UAL / |
| Hart Brett J EVP, Gen Counsel and Sec | 0.02% (70258) | ABBV / UAL / |
| Rainey John D EVP and CFO | 0.02% (64934) | NDAQ / PYPL / UAL / |
| SHAPIRO EDWARD | 0.01% (52707) | ENT / UAL / |
| Foland Jeffrey T. EVP-Mktg, Tech and Strgy | 0.01% (45856) | HTZ / LHO / UAL / |
| Foxhall Irene E Exec VP Comm & Gov Affairs | 0.01% (41683) | UAL / |
| LADERMAN GERALD SVP- Finance & Acting CFO | 0.01% (40774) | UAL / |
| MCDONALD PETER D Exec VP and COO | 0.01% (36406) | UAL / |
| Levy Andrew C EVP & CFO | 0.01% (32902) | ALGT / UAL / |
| Hart Gregory L SVP Operations | 0.01% (22279) | UAL / |
| Nocella Andrew P EVP and Chief Revenue Officer | 0.01% (20286) | AAL / UAL / |
UM